Anesthetic management for transcatheter pulmonary valve implantation

DOI Web Site
  • Ando Taichi
    Operating rooms, Kyushu University Hospital
  • Shirozu Kazuhiro
    Operating rooms, Kyushu University Hospital
  • Ozasa Shoko
    Department of Anesthesiology and Critical Care Medicine, Kyushu University Hospital
  • Karashima Yuji
    Department of Anesthesiology, National Hospital Organization Kyushu Medical Center
  • Yamaura Ken
    Department of Anesthesiology and Critical Care Medicine, Kyushu University Graduate School of Medical Sciences

Bibliographic Information

Other Title
  • 経カテーテル肺動脈弁留置術（TPVI）の麻酔管理
  • ケイ カテーテル ハイ ドウミャクベン リュウチジュツ(TPVI)ノ マスイ カンリ

Search this article

Description

<p>　Significant pulmonary valve regurgitation after congenital heart disease surgery in adults is being observed increasingly. Since 2010, transcatheter pulmonary valve implantation (TPVI) is being performed in the United States in patients with a history of multiple operations, who are considered at high risk for open heart surgery. The Harmony? Transcatheter Pulmonary Valve System (Medtronic Japan, Inc., [Harmony TPV]) was introduced into clinical practice in Japan in March 2023. It is a transcatheter implantation system that uses a porcine pericardial bioprosthetic valve attached to a self-expandable nitinol frame. Transcatheter implantation of the device is performed using a biplane X-ray angiography system. Although TPVI is minimally invasive, the caveats associated with this approach include the need for nonoperating room anesthesia management, complications attributable to poor surgical skill, procedure-related arrhythmias, and circulatory instability during valve deployment.</p><p>In this report, we describe our experience with anesthesia management in two cases of TPVI.</p>

Journal

  • Cardiovascular Anesthesia

    Cardiovascular Anesthesia 28 (1), 119-123, 2024-09-01

    Japanese Society of Cardiovascular Anesthesiologists

Keywords

Details 詳細情報について

Report a problem

Back to top